Treating Chronic Idiopathic Thrombocytopenic Purpura -- A New Application of an Old Treatment
- 2 June 1994
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 330 (22) , 1609-1610
- https://doi.org/10.1056/nejm199406023302212
Abstract
Idiopathic thrombocytopenic purpura is a common problem in hematologic practice. The acute form of the disease, which affects mainly children, is almost always self-limited. The physician's role in these cases is to tide the patient over the attack, sometimes with a brief course of corticosteroids or intravenous immune globulin. Chronic idiopathic thrombocytopenic purpura is a far more troublesome disorder. The typical patient is a woman in her 30s who bruises easily and has gingival bleeding or epistaxis and, often, menorrhagia. Petechiae are prominent findings, but splenomegaly is not a feature of the disease. Dangerous spontaneous hemorrhage is unusual, even when . . .Keywords
This publication has 9 references indexed in Scilit:
- Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone TherapyNew England Journal of Medicine, 1994
- CURATIVE EFFECT OF DEXAMETHASONE‐CYCLOPHOSPHAMIDE PULSE THERAPY FOR THE TREATMENT OF PEMPHIGUS VULGARISInternational Journal of Dermatology, 1992
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- Apoptosis in human thymocytes after treatment with glucocorticoidsClinical and Experimental Immunology, 1992
- Megadose methylprednisolone pulse therapy in adult idiopathic thrombocytopenic purpuraThe Lancet, 1991
- Modulation of human mononuclear phagocyte FcγRII mRNA and proteinCellular Immunology, 1989
- High‐Dose, pulse intravenous methylprednisolone enhances fcγ receptor–mediated mononuclear phagocyte function in systemic lupus erythematosusArthritis & Rheumatism, 1989
- High‐dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpuraEuropean Journal of Haematology, 1989
- Glucocorticosteroid‐dependent synergy between interleukin 1 and interleukin 6 for human B lymphocyte differentiationEuropean Journal of Immunology, 1988